Nabeela Khan

952 total citations
19 papers, 478 citations indexed

About

Nabeela Khan is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Nabeela Khan has authored 19 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Nabeela Khan's work include Renal cell carcinoma treatment (4 papers), Renal and related cancers (4 papers) and Cancer Genomics and Diagnostics (4 papers). Nabeela Khan is often cited by papers focused on Renal cell carcinoma treatment (4 papers), Renal and related cancers (4 papers) and Cancer Genomics and Diagnostics (4 papers). Nabeela Khan collaborates with scholars based in United States, Japan and India. Nabeela Khan's co-authors include Iram Hassan, Neha Maheshwari, Michael W. Dunn, Michal L. Schwartzman, Karsten Gronert, Bjoern Peters, Maria I. Carlo, James J. Hsieh, Julie G. Burel and Brandon J. Manley and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Nabeela Khan

17 papers receiving 471 citations

Peers

Nabeela Khan
Desiree Anthony Australia
Z Yasruel Canada
Robert T. Kitchens United States
Jamye F. O’Neal United States
Xiao-Wu Qu United States
Anke Werner Germany
Young Sun Kim South Korea
Nabeela Khan
Citations per year, relative to Nabeela Khan Nabeela Khan (= 1×) peers Glynis Klinke

Countries citing papers authored by Nabeela Khan

Since Specialization
Citations

This map shows the geographic impact of Nabeela Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nabeela Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nabeela Khan more than expected).

Fields of papers citing papers by Nabeela Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nabeela Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nabeela Khan. The network helps show where Nabeela Khan may publish in the future.

Co-authorship network of co-authors of Nabeela Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Nabeela Khan. A scholar is included among the top collaborators of Nabeela Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nabeela Khan. Nabeela Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Khan, Nabeela, Akul Singhania, Ferran Soldevila, et al.. (2023). Single-cell profiling reveals distinct subsets of CD14+ monocytes drive blood immune signatures of active tuberculosis. Frontiers in Immunology. 13. 1087010–1087010. 12 indexed citations
3.
Clister, Terri, et al.. (2023). Advances in Early Detection of Melanoma and the Future of At-Home Testing. Life. 13(4). 974–974. 19 indexed citations
4.
Mahmood, Asad, et al.. (2022). Frequency of t(4;14) in Multiple Myeloma and Its Clinicopathological Correlation. Pakistan Armed Forces Medical Journal. 72(SUPPL-2). S103–6.
5.
Mazzu, Ying Z., Joshua Armenia, Subhiksha Nandakumar, et al.. (2020). Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer. Molecular Oncology. 14(8). 1881–1897. 23 indexed citations
6.
Khan, Nabeela, et al.. (2019). DIAGNOSTIC ACCURACY OF RETICULOCYTE HAEMOGLOBIN EQUIVALENT (RETHE) IN DETECTING IRON DEFICIENCY ANAEMIA KEEPING SERUM FERRITIN AS GOLD STANDARD. SHILAP Revista de lepidopterología. 1 indexed citations
7.
Burel, Julie G., Mariana Babor, Mikhail Pomaznoy, et al.. (2019). Host Transcriptomics as a Tool to Identify Diagnostic and Mechanistic Immune Signatures of Tuberculosis. Frontiers in Immunology. 10. 221–221. 28 indexed citations
8.
Chakraborty, Goutam, Mohammad Atiq, Subhiksha Nandakumar, et al.. (2019). Abstract 2534: A comparative analysis of fraction genome altered vs tumor mutational count in prostate cancer. Cancer Research. 79(13_Supplement). 2534–2534. 1 indexed citations
9.
Khan, Nabeela, Goutam Chakraborty, Subhiksha Nandakumar, et al.. (2019). Abstract 283: Combination treatment of PARP and SRC inhibitors in BRCA2 mutated prostate cancer. Cancer Research. 79(13_Supplement). 283–283. 1 indexed citations
10.
Carlo, Maria I., Nabeela Khan, Ahmet Zehir, et al.. (2019). Comprehensive Genomic Analysis of Metastatic Non–Clear-Cell Renal Cell Carcinoma to Identify Therapeutic Targets. JCO Precision Oncology. 3(3). 1–18. 13 indexed citations
11.
Khan, Nabeela, Konrad H. Stopsack, Emma H. Allott, et al.. (2019). Intratumoral Sterol-27-Hydroxylase (CYP27A1) Expression in Relation to Cholesterol Synthesis and Vitamin D Signaling and Its Association with Lethal Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention. 28(6). 1052–1058. 14 indexed citations
13.
Burel, Julie G., Cecilia S. Lindestam Arlehamn, Nabeela Khan, et al.. (2018). Transcriptomic Analysis of CD4+ T Cells Reveals Novel Immune Signatures of Latent Tuberculosis. The Journal of Immunology. 200(9). 3283–3290. 36 indexed citations
14.
Chakraborty, Goutam, Joshua Armenia, Ying Z. Mazzu, et al.. (2018). BRCA2-RB1 co-loss and ADT resistance in aggressive prostate cancer.. Journal of Clinical Oncology. 36(15_suppl). e17024–e17024. 1 indexed citations
15.
Masoodi, Shariq Rashid, et al.. (2018). Variations in the inhibin gene in Kashmiri women with primary ovarian insufficiency. Human Fertility. 23(2). 111–116. 2 indexed citations
16.
Manley, Brandon J., Emily C. Zabor, Maria F. Becerra, et al.. (2017). Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy. Urologic Oncology Seminars and Original Investigations. 35(8). 532.e7–532.e13. 22 indexed citations
17.
Carlo, Maria I., Nabeela Khan, Ying‐Bei Chen, et al.. (2017). The genomic landscape of metastatic non-clear cell renal cell carcinoma.. Journal of Clinical Oncology. 35(6_suppl). 474–474. 1 indexed citations
18.
Hsieh, James J., Brandon J. Manley, Nabeela Khan, et al.. (2016). Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer. Seminars in Cell and Developmental Biology. 64. 98–106. 37 indexed citations
19.
Gronert, Karsten, Neha Maheshwari, Nabeela Khan, et al.. (2005). A Role for the Mouse 12/15-Lipoxygenase Pathway in Promoting Epithelial Wound Healing and Host Defense. Journal of Biological Chemistry. 280(15). 15267–15278. 257 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026